Roth Capital Downgrades Galectin Therapeutics (GALT) to Sell

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. MRK
6. MRNA
7. ADI
8. LOW
9. WMT
10. TJX

Go back to Roth Capital Downgrades Galectin Therapeutics (GALT) to Sell
GALECTIN (NASDAQ: GALT) Delayed: 3.65 -0.02 (0.54%)
Previous Close $3.67    52 Week High $3.05 
Open $3.67    52 Week Low $0.49 
Day High $3.75    P/E N/A 
Day Low $3.44    EPS $-1.32 
Volume 226,149